Afrezza (MNKD) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
MannKind Corporation (MNKD) narxlar tarixi diabetga chalinganlar uchun noyob kukunli inhalatsiya tizimiga egaligi va himoyalangan patentlariga asoslangan kompaniyaning dinamikasini aks ettiradi. Joriy ko'rsatkich 0.00 ni tashkil etadi. Biznes inyeksiyalarga muqobil variantlar yo'qligi sababli o'z yechimlarining yuqori narxiga tayanadi, operatsion samaradorlik esa logistika va sinovlarni tashqi pudratchilarga topshirish orqali oshiriladi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261031&filename=GURU_Markets_-_MNKD_-_MannKind-Corporation_-_Long-Term-Debt-to-Capital "MNKD: MannKind Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 | 👁️GURU.Markets👁️")
MannKind Corporation (MNKD) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati MannKind Corporation|MNKD - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati mannkindcorp.com|MNKD - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati MannKind Corporation|MNKD - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz MannKind|Oraliq likvidlik koeffitsiyenti mannkindcorp.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:MannKind Corp - MNKD
Himoyaviy aktivlarning tanlanishi minimal qarz yukiga asoslangan bo'lib, bu MannKind Corporation (MNKD) kompaniyasi o'sib borayotgan inhalatsiya orqali diabet terapiyasi segmentiga kengayayotgan davrida juda muhimdir. Uzoq muddatli qarzning kapitalga nisbati kapital tuzilmasi ichidagi muddati bir yildan ortiq bo'lgan kreditlar ulushini o'lchaydi, bu esa investorlarga balansning barqarorligini va kompaniyaning defolt xavfisiz o'sishni moliyalashtirish qobiliyatini baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Haleon PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati KVUE|VRNA (Verona Pharma Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MENS (Jyong Biotech Ltd)|Uzoq muddatli qarzning kapitalga nisbati ligand.com LGND|AMRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Liquidia Inc.|GLPG (Galapagos NV) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati anipharmaceuticals.com|Uzoq muddatli qarzning o'z kapitaliga nisbati AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ARS Pharma SPRY|Theravance Corp (TBPH) - Uzoq muddatli majburiyatlarning kapitalga nisbati|AQST: Uzoq muddatli qarzning o'z kapitaliga nisbati|scPharmaceuticals Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|TECX: Uzoq muddatli qarzning kapitalga nisbati|Tonix Pharma - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SXTC (SXT Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Eupraxia Pharma EPRX|Uzoq muddatli qarzning o'z kapitaliga nisbati BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Oramed Pharmaceuticals Inc. ORMP|ENTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|MindWalk - Uzoq muddatli qarzning kapitalga nisbati|ABVC - Uzoq muddatli qarzning kapitalga nisbati|Cumberland Pharmaceuticals (CPIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi QNTM|Uzoq muddatli qarzning o'z kapitaliga nisbati FibroGen|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TELO (Telomir Pharmaceuticals Inc)|Uzoq muddatli qarzning o'z kapitaliga nisbati Rani Therapeutics (RANI)|Uzoq muddatli qarzning kapitalga nisbati synergychc.com (SNYR)|Uzoq muddatli qarzning kapitalga nisbati RLYB (Rallybio)|Uzoq muddatli qarzdorlikning kapitalga nisbati Lexaria Bioscience Corp (LEXX)|PULM - Uzoq muddatli qarzning o'z kapitaliga nisbati|PTHL (Pheton Holdings Ltd) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|APM: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi LYRA|Uzoq muddatli qarzning o'z kapitaliga nisbati IBO|TNFA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati YCBD|Uzoq muddatli qarzning o'z kapitaliga nisbati PainReform Ltd PRFX|Uzoq muddatli qarzning o'z kapitaliga nisbati Altamira Therapeutics Ltd. CYTO|Lipella Pharma (LIPO) - Uzoq muddatli majburiyatlarning kapitalga nisbati|OPTN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PIRS (pieris.com)|Procaps (PROC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati PTPI (Petros Pharmaceuticals Inc)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qilian International Holding Group Limited|Uzoq muddatli majburiyatlarning kapitalga nisbati ACELYRIN Inc. SLRN|Uzoq muddatli qarzning o'z kapitaliga nisbati TFF Pharmaceuticals (TFFP)